- Crucell Announces Start of Phase II Clinical Study Rabies ... - FOXBusiness
- Generex Study Proposes Increased Reporting of Clinical Outcomes to ... - FOXBusiness
- Generex Biotechnology to Make Presentations At International ... - FOXBusiness
- Generex Biotechnology Raises $20650000 Through Private Placement - FOXBusiness
- Abraxis BioScience Reports 83% Revenue Growth to a Record $334 ... - FOXBusiness
Start of Phase II Clinical Study for Rabies Monoclonal Antibody ... - FOXBusiness
Start of Phase II Clinical Study for Rabies Monoclonal Antibody ...FOXBusiness - May 12, 2008Phase I clinical trials conducted in the United States and India demonstrated safety and the ability to protect. The antibody combination is well tolerated, ...
